| Primary |
| Attention Deficit/hyperactivity Disorder |
67.3% |
| Adhd |
15.4% |
| Migraine |
7.7% |
| Disturbance In Attention |
3.8% |
| Add |
1.9% |
| Narcolepsy |
1.9% |
| Product Used For Unknown Indication |
1.9% |
|
| Product Substitution Issue |
40.0% |
| Product Quality Issue |
6.7% |
| Tic |
6.7% |
| Myalgia |
4.4% |
| Psychiatric Symptom |
4.4% |
| Psychotic Disorder |
4.4% |
| Somnolence |
4.4% |
| Accidental Exposure To Product |
2.2% |
| Fatigue |
2.2% |
| Haematochezia |
2.2% |
| Hallucination, Visual |
2.2% |
| Headache |
2.2% |
| Mania |
2.2% |
| Medication Error |
2.2% |
| Myocardial Infarction |
2.2% |
| Nausea |
2.2% |
| No Adverse Event |
2.2% |
| Physical Assault |
2.2% |
| Poisoning |
2.2% |
| Pruritus Generalised |
2.2% |
|
| Secondary |
| Product Used For Unknown Indication |
27.7% |
| Attention Deficit/hyperactivity Disorder |
18.5% |
| Drug Dependence |
8.9% |
| Depression |
7.5% |
| Anxiety |
5.5% |
| Drug Abuse |
5.5% |
| Major Depression |
2.7% |
| Pain |
2.7% |
| Bipolar Disorder |
2.4% |
| Foetal Exposure During Pregnancy |
2.4% |
| Blood Oestrogen Increased |
2.1% |
| Depressive Disorder |
2.1% |
| Migraine |
2.1% |
| Progesterone Decreased |
2.1% |
| Sleep Disorder |
1.7% |
| Substance Abuse |
1.7% |
| Affective Disorder |
1.4% |
| Convulsion |
1.0% |
| Hypersensitivity |
1.0% |
| Insomnia |
1.0% |
|
| Suicidal Ideation |
11.3% |
| Serotonin Syndrome |
8.1% |
| Off Label Use |
6.5% |
| Weight Decreased |
6.5% |
| Wrong Technique In Drug Usage Process |
6.5% |
| Drug Abuse |
4.8% |
| Drug Hypersensitivity |
4.8% |
| Somnolence |
4.8% |
| Suicide Attempt |
4.8% |
| Syncope |
4.8% |
| Theft |
4.8% |
| Unresponsive To Stimuli |
4.8% |
| Weight Increased |
4.8% |
| Antiphospholipid Antibodies Positive |
3.2% |
| Drug Dependence |
3.2% |
| Limb Injury |
3.2% |
| Overdose |
3.2% |
| Restlessness |
3.2% |
| Sinus Tachycardia |
3.2% |
| Substance Abuse |
3.2% |
|
| Concomitant |
| Product Used For Unknown Indication |
39.2% |
| Attention Deficit/hyperactivity Disorder |
9.9% |
| Depression |
7.2% |
| Multiple Sclerosis |
6.5% |
| Anxiety |
4.3% |
| Pain |
3.7% |
| Bipolar Disorder |
3.3% |
| Contraception |
3.2% |
| Agoraphobia |
2.4% |
| Rheumatoid Arthritis |
2.4% |
| Insomnia |
2.2% |
| Crohn's Disease |
2.2% |
| Sleep Disorder |
2.2% |
| Intervertebral Disc Protrusion |
2.1% |
| Hypertension |
1.7% |
| Gastrooesophageal Reflux Disease |
1.7% |
| Acne |
1.5% |
| Asthma |
1.5% |
| Psoriasis |
1.4% |
| Back Pain |
1.4% |
|
| Weight Increased |
11.2% |
| Pain |
8.7% |
| Vomiting |
8.0% |
| Weight Decreased |
7.4% |
| Injection Site Pain |
7.1% |
| Pulmonary Embolism |
6.4% |
| Nausea |
5.8% |
| Suicidal Ideation |
5.1% |
| Off Label Use |
4.8% |
| Drug Ineffective |
4.2% |
| Pain In Extremity |
3.8% |
| Visual Impairment |
3.8% |
| Urinary Tract Infection |
3.5% |
| Menstruation Irregular |
3.2% |
| Rash |
3.2% |
| Tremor |
3.2% |
| Convulsion |
2.9% |
| Sinusitis |
2.9% |
| Vision Blurred |
2.6% |
| Deep Vein Thrombosis |
2.2% |
|
| Interacting |
| Blood Pressure Abnormal |
12.5% |
| Depression |
12.5% |
| Product Used For Unknown Indication |
12.5% |
| Blood Glucose Increased |
6.3% |
| Chronic Myeloid Leukaemia |
6.3% |
| Depressed Level Of Consciousness |
6.3% |
| Disturbance In Attention |
6.3% |
| Ejaculation Disorder |
6.3% |
| Erectile Dysfunction |
6.3% |
| Hypertension |
6.3% |
| Narcolepsy |
6.3% |
| Smoking Cessation Therapy |
6.3% |
| Substance-induced Mood Disorder |
6.3% |
|
| Feeling Jittery |
12.5% |
| Inhibitory Drug Interaction |
12.5% |
| Lip And/or Oral Cavity Cancer |
12.5% |
| Road Traffic Accident |
12.5% |
| Somnolence |
12.5% |
| Thinking Abnormal |
12.5% |
| Thrombosis In Device |
12.5% |
| Tremor |
12.5% |
|